Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference
BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused…
0,343€
-3,79%
Echtzeit-Aktienkurs Sensei Biotherapeutics Inc.
Bid:
Ask:
Nachrichten zur Sensei Biotherapeutics Inc. Aktie
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium
BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused…